000 New Zealanders that suffer from the pain of migraine headaches.

For more information, contact Dr Rod Lea on 04 472 1000 ext 7623 or 021 188 7876 Issued by Victoria University of Wellington General public Affairs For more info please get in touch with phone or nz 04 463 5873 or 029 463 5873.. A straightforward dietary supplement can help to prevent strokes A straightforward dietary supplement may not only give relief for some of the more than 400,000 New Zealanders that suffer from the pain of migraine headaches, but may also help to prevent strokes. That’s the look at of Victoria University genetic epidemiologist, Dr Rod Lea, who, with colleagues at Brisbane’s Griffith University, has found out a gene that is from the most debilitating and serious form of headache, migraine with aura. About 12 % or 480,000 New Zealanders are estimated to have problems with migraines with women much more likely to become affected by the problem than men.This gives researchers with the information required to draw meaningful conclusions from their experimental data. The Colorectal Cancer DSA research tool contains 61,528 probesets covering 52,306 colorectal expressed transcripts: 21,968 are present in the individual RefSeq database 26,676 of transcripts aren’t within the human RefSeq data source 7 percent of this content represents expressed antisense transcripts to annotated genes To day, Almac Diagnostics offers launched Colorectal Cancer Breast and DSA Tumor DSA. In June Lung Cancers DSA will be launched, and Ovarian Malignancy DSA and Prostate Tumor DSA will be released later this year. The successful clinical software of the Colorectal Cancer DSA research device was first demonstrated in colorectal cancers as a prognostic signature in stage II colorectal cancer to identify patients at risky of relapse post medical procedures.